World Cancer Day is an international day marked on February 4 to raise awareness of cancer and to encourage its prevention, detection, and treatment. Cancer is the leading cause of disease-related death among working-age adults in high-income and middle-income countries.

This World Cancer Day, we’re shining a light on our commitment to our employees impacted by cancer. We are reimagining cancer in the workplace through the global program ‘Ensemble – Caring for colleagues’ with oncology experts and human resources personel, who serve as internal volunteers.

…

• Successful acquisition of Aspen’s Japanese operations and assets reinforces strategic focus on Japan, world’s third largest market for generics and off-patent medicines
• Acquired portfolio complements existing Sandoz portfolio and consists primarily of off-patent branded medicines with focus on anaesthetics and specialty brands
• Transaction enables Sandoz to increase portfolio and pipeline offerings in hospital setting, expanding number of patients who can gain access to these important medicines  

Holzkirchen, …

• Successful acquisition of Aspen’s Japanese operations and assets reinforces strategic focus on Japan, world’s third largest market for generics and off-patent medicines
• Acquired portfolio complements existing Sandoz portfolio and consists primarily of off-patent branded medicines with focus on anaesthetics and specialty brands
• Transaction enables Sandoz to increase portfolio and pipeline offerings in hospital setting, expanding number of patients who can gain access to these important medicines  

Holzkirchen, …

• Sandoz officially recognized by Top Employers Institute for its exceptional employee offerings globally
• People-first policies such as global equal parental leave for 14 weeks and joining the Equal Pay International Coalition contributed to recognition
• Second such annual certification for Sandoz, underlining ongoing commitment to attract and keep best talent by building a great place to work

Holzkirchen, January 30, 2020 – Sandoz, a Novartis division, is pleased to announce that it has been officially awarded the “Global Top Employer 2020” …

• Full year net sales for continuing operations¹ up 9% (cc², +6% USD):
  • Pharmaceuticals BU growing 12% (cc) driven by Cosentyx USD 3.6 billion (+28% cc), Entresto USD 1.7 billion (+71% cc) and Zolgensma USD 361 million
  • Oncology BU growing 10% (cc) driven by Promacta/Revolade USD 1.4 billion (+23% cc), Kisqali USD 0.5 billion (+111% cc) and Lutathera USD 0.4 billion (+160% cc)
  • Sandoz sales grew 2% (cc, -1% USD) driven by Biopharmaceuticals …